HealtheRx Survey for Pulmonary Research Registry Recruitment

Not Applicable

Completed

• Conditions: COPD; Asthma
• Interventions: Other: HealtheRx+; Other: HealtheRx++

• Registration Number: NCT02653066
• Lead Sponsor: University of Chicago

Brief Summary

The purpose of this research is to study the utility of using the HealtheRx as a tool to recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the University of Chicago. HealtheRx is an example of a potential recruitment tool that has high reach in populations typically underrepresented in research studies, uses a high tech infrastructure that allows matching of research opportunities to patient characteristics, but that delivers information in a low-tech, patient-centered mode using the printed HealtheRx prescription.

Detailed Description

1. Patients living in one of 16 zip codes of the South and West Sides of Chicago who present for care at one or more of 30 clinical sites receive a personalized HealtheRx prescription with programs and services in the community from their health care provider. The HealtheRx is printed and delivered to the patient at the end of the visit.

2. Patients age 18+ with a diagnosis of asthma and/or COPD will receive a HealtheRx with programs/services to help manage their condition, as well as an advertisement to participate in a phone survey.

3. Patients interested in completing the phone survey can call or text the Lindau Lab at the University of Chicago.

4. An experienced survey researcher will first read the consent script and if oral consent is received, continue with the phone survey (The survey includes items pertaining to program participants' receipt of the HealtheRx, use of community services provided on the HealtheRx, thoughts about participation in clinical research.

5. Participants who choose to complete the survey will receive a $10 check delivered via U.S. mail to their home address. Patients interested in joining the PRR will receive the PRR consent form with their $25 check.

6. Participants with interest in joining the PRR will also receive, via mail, a $5 bill as thanks for reading, signing and returning the consent form. Participants will be randomized to receive the $5 bill at 2 different time points.

7. Once the signed consent form is received, a member of the Asthma and COPD Center research staff will contact the participant by phone and complete the PRR case report form by phone.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2015-12
• Study First Submitted: 2016-01-08
• Study First Submitted QC: 2016-01-11
• Study First Posted: 2016-01-12
• Primary Completion: 2017-04-25
• Study Completion: 2019-12
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-27
• Last Update Posted: 2020-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

• diagnosis of asthma/COPD
• receipt of HealtheRx

Read More

Exclusion Criteria

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention with consent form	HealtheRx+	After completing survey, participant in HealtheRx+ group receives $5 bill with their survey check and blank registry consent form.
Intervention with return of consent form	HealtheRx++	After returning signed consent form, participant in HealtheRx++ group is mailed $5 bill.

Primary Outcome Measures

Name	Time	Method
Cost per consented subject	6 months

Secondary Outcome Measures

Name	Time	Method
Mean number of consented subjects per week	6 months

Trial Locations

Locations (1)

University of Chicago; 🇺🇸 Chicago, Illinois, United States